Aims & Scope

Aims: 

Cancer Pathobiology and Immunity (CPI) is a gold open access, peer-reviewed journal giving international coverage across all disciplines of cancer and focusing on pathobiologic and immunity research. The journal publishes regular research papers, reviews, perspectives, opinions, commentaries, and case reports covering all aspects of oncology from pathogenesis to diagnosis and personalized management. The goal is to improve the quality and effectiveness of treatments based on scientific knowledge of cancer pathobiology and immunity. Oncologists, pathologists, cellular biologists, clinical and experimental immunologists, and molecular biologists and pathologists are invited to contribute to CPI. Clinical data regarding diagnosis and treatment are primarily addressed to clinical specialists, while advances in pathogenesis, genetics, immunogenetics, and immunotherapy about neoplastic diseases are primarily addressed to clinical and experimental researchers. Initially, articles will be published quarterly online by Scilight Press.

Scope:

CPI welcomes findings derived from the application of molecular and cellular biology, pathology, genetics, genomics, immunology, molecular virology, and data science to address new cancer treatments. The journal addresses oncological problems that provide mechanistic insights and innovative approaches important for the fields of cancer management. The new treatments comprise a wide variety of agents, including small molecules, biologics, and immunologics.